๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies

โœ Scribed by Wolfgang Miesbach; Inge Scharrer; Ronald Asherson

Publisher
Springer
Year
2006
Tongue
English
Weight
93 KB
Volume
25
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Thrombotic thrombocytopenic purpura with
Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome
โœ Zahir Amoura; Nathalie Costedoat-Chalumeau; Agnรจs Veyradier; Martine Wolf; Pasca ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB ๐Ÿ‘ 2 views

## Abstract Arterial thrombotic events, thrombocytopenia, and hemolytic anemia with schistocytes may be encountered in the setting of both thrombotic thrombocytopenic purpura (TTP) and primary antiphospholipid syndrome (APS). We report 2 cases of TTP occurring in patients with definite primary APS.

Different manifestations of the antiphos
Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus
โœ Kimberly P. May; Sterling G. West; Joann Moulds; Brian L. Kotzin ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 524 KB

Familial associations of the antiphospholipid antibody syndrome (APS) offer the opportunity to study genetic mechanisms of autoantibody production and disease, but are unusual. We identified a family, including identical twins and their mother, in which all members had systemic lupus erythematosus (

Increased platelet deposition on extrace
Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events
โœ Yair Levy; Boris Shenkman; Ilia Tamarin; Rachel Pauzner; Yehuda Shoenfeld; Pnina ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 129 KB

## Abstract ## Objective To assess platelet function under defined flow conditions in patients with antiphospholipid syndrome (APS) and to correlate the results with thrombotic complications and the presence of subsets of antiphospholipid antibodies (aPL), lupus anticoagulant (LAC), and/or anticar